Overview Latest Regional Industry Featured Multimedia Other Languages Public Company News
KAZIA TO PRESENT AT UPCOMING INVESTOR CONFERENCE AND AACR ANNUAL SCIENTIFIC MEETING 2022-03-21 20:00
Nuance Pharma Announces License and Supply Agreement with Bavarian Nordic on the Development and Commercialization of Respiratory Syncytial Virus (RSV) Vaccine for Adults in China and Selected Asian Markets 2022-03-21 16:20
Genscript Biotech Reports 2021 Annual Results 2022-03-20 22:47
Joint Fight Against COVID-19, Viva Biotech Contributes to the Production of the Oral COVID-19 Antiviral Medication and Virus Tests 2022-03-18 17:47
HitGen Announces Research Collaboration Focused on DNA-Encoded Library Based Drug Discovery 2022-03-17 22:30
China CDE Approved First Universal CAR-T IND ! 2022-03-17 21:32
Triastek and Siemens announce strategic collaboration to accelerate digital transformation of the pharmaceutical industry 2022-03-17 21:24
Seegene appoints Dr. Glen Hansen as Head of Medical Affairs of U.S. subsidiary 2022-03-17 20:00
I Peace triples GMP cell manufacturing by expanding CDMO facility 2022-03-15 03:22
Sirnaomics to Present Latest Developments on its GalNAc-Based Liver-Targeting Platforms and Product Pipeline at the 2022 Oligonucleotide & Precision Therapeutics Congress 2022-03-15 00:06
MediLink Therapeutics closes US$70 million Series B financing 2022-03-14 20:50
WuXi Biologics Recognized as 2022 Top-Rated ESG Company by Sustainalytics 2022-03-14 20:30
NuclixBio Announces a Collaborative Research Agreement with PharmAbcine 2022-03-14 20:00
Bridge Biotherapeutics to Present Preclinical Data of BBT-207 at the AACR 2022 Annual Meeting 2022-03-10 07:00
Ascentage Pharma to Present Latest Results from Six Preclinical Studies at AACR Annual Meeting 2022 2022-03-09 07:47
ProfoundBio to Highlight Programs and Technology at AACR 2022 Annual Meeting; Welcomes Zhu Chen, PhD, as Chief Scientific Officer 2022-03-09 06:58
Gracell Biotechnologies Announces Details of Poster Presentation at AACR Annual Meeting 2022 2022-03-09 05:30
WuXi ATU Announces Launch of TESSA™ Technology to Improve Scalability and Accessibility of Cell and Gene Therapies 2022-03-08 08:00
Bridge Biotherapeutics Enters into an Option-to-License Agreement with CellionBioMed to Develop BBT-301 for the Treatment of Multiple Fibrotic Diseases 2022-03-08 08:00
Singleron Acquires Proteona 2022-03-07 23:00
1 67 68 69 70 71 204